Evaluation of circulating endothelial cells as noninvasive marker of angiogenesis in patients with chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 50, Issue 1, 2009, Pages 62-67

  Gora Tybor, Joanna ^a   Jamroziak, Krzysztof ^a   Szmigielska Kaplon, Anna ^a   Krawczynska, Anna ^a   Lech Maranda, Ewa ^a   Wierzbowska, Agnieszka ^a   Jesionek Kupnicka, Dorota ^a   Blonski, Jerzy Z ^a   Robak, Tadeusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Angiogenesis; Bone marrow microvessels density; Chronic lymphocytic leukemia; Circulating endothelial cells

Indexed keywords

ADULT; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; BONE MARROW; BONE MARROW BIOPSY; CANCER STAGING; CELL ACTIVATION; CELL COUNT; CELL POPULATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; STEM CELL;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BONE MARROW; CELL MOVEMENT; ENDOTHELIAL CELLS; FEMALE; HEALTH; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS;

EID: 59249106236     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802549883     Document Type: Article

References (27)

1. Letilovic, T., Vrhovac, R., Verstovsek, S., Jaksic, B. and Ferrajoli, A. (2006) Role of angiogenesis in chronic lymphocytic leukemia. Cancer, 107, pp. 925-934.
2. Shanafelt, T. D. and Kay, N. E. (2006) The clinical and biologic importance of neovascularization and angiogenicsignaling pathways in chronic lymphocytic leukemia. Semin Oncol, 33, pp. 174-185.
3. Molica, S., Vacca, A., Ribatti, D., Cuneo, A., Cavazzini, F. Levato, D. et al. (2002) Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia. Blood, 100, pp. 3344-3351.
4. Molica, S., Vacca, A., Levato, D., Merchionne, F. and Ribatti, D. (2004) Angiogenesis in acute and chronic lymphocytic leukemia. Leuk Res, 28, pp. 321-324.
5. Chen, H., Treweeke, A. T., West, D. C., Till, K. J., Cawley, J. C. Zuzel, M. et al. (2000) In vitro and in vivo production of vascular endothelial growth factor by chronic lymphocytic leukemia cells. Blood, 96, pp. 3181-3187.
6. Gora-Tybor, J., Blonski, J. Z. and Robak, T. (2003) Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia. Mediators Inflamm, 12, pp. 167-171.
7. Menzel, T., Rahman, Z., Calleja, E., White, K., Wilson, E. L. Wieder, R. et al. (1996) Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabine. Blood, 87, pp. 1056-1063.
8. Kay, N. E., Bone, N. D., Tschumper, R. C., Howell, K. H., Geyer, S. M. Dewald, G. W. et al. (2002) B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules. Leukemia, 16, pp. 911-919.
9. Molica, S., Vitelli, G., Levato, D., Ricciotti, A. and Digiesi, G. (2002) Clinicoprognostic implications of increased serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in early B-cell chronic lymphocytic leukaemia. Br J Cancer, 86, pp. 31-35.
10. Aguayo, A., O'Brien, S., Keating, M., Manshouri, T., Gidel, C. Barlogie, B. et al. (2000) Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia. Blood, 96, pp. 768-770.
11. Moldovan, N. I. (2003) Current priorities in the research of circulating pre-endothelial cells. Adv Exp Med Biol, 522, pp. 1-8.
12. Gunsilius, E. (2003) Evidence from a leukemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Adv Exp Med Biol, 522, pp. 17-24.
13. Lin, Y., Weisdorf, D. J., Solovey, A. and Hebbel, R. P. (2000) Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest, 105, pp. 71-77.
14. Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P. Butros, L. et al. (2001) Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med, 7, pp. 1194-1201.
15. Monestiroli, S., Mancuso, P., Burlini, A., Pruneri, G., Dell'Agnola, C. Gobbi, A. et al. (2001) Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma. Cancer Res, 61, pp. 4341-4344.
16. Cheson, B. D., Bennett, J. M., Grever, M., Kay, N., Keating, M. J. O'Brien, S. et al. (1996) National cancer institute sponsored working group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment. Blood, 87, pp. 4990-4997.
17. Rai, K. R., Sawitsky, A., Cronkite, E. P., Chanana, A. D., Levis, R. N. and Pasternack, B. S. (1975) Clinical staging of chronic lymphocytic leukemia. Blood, 46, pp. 219-234.
18. Rai, K. R. (1987) A critical analysis of staging in CLL. Chronic Lymphocytic Leukemia: Recent Progress and Future Directions, pp. 153-264. Alan R. Liss, New York
19. Mancuso, P., Burlini, A., Pruneri, G., Goldhirsch, A., Martinelli, G. and Bertolini, F. (2001) Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood, 97, pp. 3658-3661.
20. Go, R. S., Jobe, D. A., Asp, K. E., Callister, S. M., Mathiason, M. A. Meyer, L. A. et al. (2008) Circulating endothelial cells in patients with chronic lymphocytic leukemia. Ann Hematol, 87, pp. 369-373.
21. Mancuso, P., Colleoni, M., Calleri, A., Orlando, L., Maisonneuve, P. Pruneri, G. et al. (2006) Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy. Blood, 108, pp. 452-459.
22. Cortelezzi, A., Fracchiolla, N. S., Mazzeo, L. M., Silvestris, I., Pomati, M. Somalvico, F. et al. (2005) Endothelial precursors and mature endothelial cells are increased in the peripheral blood of myelodysplastic syndromes. Leuk Lymphoma, 46, pp. 1345-1351.
23. Beerepoot, L. V., Mehra, N., Vermaat, J SP, Zonnbenberg, B. A., Gebbink, M. F. and Voest, E. E. (2004) Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients. Ann Oncol, 15, pp. 139-145.
24. Wierzbowska, A., Robak, T., Krawczynska, A., Pluta, A., Wrzesien-Ku;, A. Cebula, B. et al. (2008) Kinetics and apoptotic profile of circulating endothelial cells as prognostic factors for induction treatment failure in newly diagnosed acute myeloid leukemia patients. Ann Hematol, 87, pp. 97-106.
25. Szmigielska-Kapłon, A., Jesionek-Kupnicka, D., Gora-Tybor, J., Błonski, J. Z., Lech-Maranda, E. Kordek, R. et al. (2007) Influence of cladribine alone and in combination with cyclophosphamide or cyclophosphamide and mitoxantrone on bone marrow angiogenesis in chronic lymphocytic leukemia. Leuk Lymphoma, 48, pp. 1042-1044.
26. Kini, A. R., Kay, N. E. and Peterson, L. C. (2000) Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia. Leukemia, 14, pp. 1414-1418.
27. Aguayo, A., Kantarjian, H., Manshouri, T., Gidel, C., Estey, E. Thomas, D. et al. (2000) Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood, 96, pp. 2240-2245.